City

Minneapolis (1)

Pittsburgh (1)

Condition

Inherited Metabolic Disorders (IMD) (2)

Congenital Bone Marrow Failure Syndromes (1)

Hereditary Anemias (1)

Inflammatory Conditions (1)

Primary Immunodeficiency (PID) (1)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

Sponsor

Magenta Therapeutics, Inc. (1)

Paul Szabolcs (1)

Collaborator

Intervention

data collection (1)

safety and efficacy assessments (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Observational (2)

inherited metabolic disorders (imd)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Recruiting

Primary Immunodeficiency (PID)
+4 more

data collection

Pittsburgh, Pennsylvania

UPMC Children's Hospital of Pittsburgh

Feb 9, 2022

Inherited Metabolic Disorders Who Underwent Hematopoietic Stem

Terminated

Inherited Metabolic Disorders (IMD)

Safety and efficacy assessments

Minneapolis, Minnesota

University of Minnesota

Mar 10, 2021